课题基金 / 基金详情

项目摘要

项目成果

VLADIMIR BOGDANOV的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 我,弗拉基米尔·波格丹诺夫,申请这个研究发展奖是为了完成我向独立研究科学家的转变。近期目标是:1)获得新的实验室技能,并产生新的研究数据,使我能够竞争定期研究项目资助支持(RO1),2)获得作为主要研究者的第一手经验,3)在阐明单核细胞中人类组织因子(TF)前mRNA加工调节机制方面取得实质性进展。具体来说,我建议研究的监管机制,负责产生的选择性剪接的人组织因子(asHTF)在单核细胞。asHTF是最近鉴定的分子,是由可变剪接产生的可溶性生物活性形式的人组织因子。它存在于循环血液和血栓中,并在剪切条件下与血小板相互作用。全长膜结合TF和asHTF都存在于动脉和离体血栓中。初步结果表明,循环单核细胞作为人血浆中asHTF蛋白的主要来源之一。因此,单核细胞中组织因子前体mRNA剪接的机制是所提出的研究的主要研究目标。此外,我建议通过一种新的RNA干扰技术来实现单核细胞中全长膜结合TF和asHTF mRNA的选择性下调,并评估这种下调对单核细胞总凝血潜力的影响。
英文摘要
DESCRIPTION (provided by applicant): I, Vladimir Bogdanov, am applying for this research development award in order to finalize my transition into an independent research scientist. The immediate goals are: 1) to acquire new laboratory skills and generate novel research data that would enable me to compete for regular research project grant support (RO1), 2) to acquire first-hand experience in being a principal investigator, and 3) to make substantial progress in elucidating the mechanisms involved in regulation of human tissue factor (TF) pre-mRNA processing in monocytic cells. Specifically, I propose to study regulatory mechanisms responsible for generation of alternatively spliced human tissue factor (asHTF) in monocytes. asHTF, a recently identified molecule, is a soluble, biologically active form of human tissue factor generated by alternative splicing. It is present in circulating blood and thrombi and interacts with platelets under shear conditions. Full-length membrane-bound TF and asHTF are both present in arterial and ex-vivo thrombi. Initial results show that circulating monocytes serve as one of the major sources of asHTF protein in human plasma. Thus, mechanics of tissue factor pre-mRNA splicing in monocytic cells is the primary research objective of the proposed study. In addition, I propose to achieve selective down-regulation of full-length membrane bound TF and asHTF mRNA in monocytic cells by a novel technique of RNA interference and assess the impact of this down-regulation on the total coagulant potential of monocytic cells.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay.
冠状动脉疾病患者血浆组织因子活性的评估:商业测定的局限性。
DOI: 10.1111/j.1538-7836.2009.03315.x
发表时间: 2009
期刊: Journal of thrombosis and haemostasis : JTH
影响因子: --
作者: [Bogdanov,VY, Cimmino,G, Tardos,JG, Tunstead,JR, Badimon,JJ]
通讯作者: Badimon,JJ
DOI: 10.1161/circresaha.108.183905
发表时间: 2009-03-13
期刊: CIRCULATION RESEARCH
影响因子: 20.1
作者: [Eisenreich, Andreas, Bogdanov, Vladimir Y., Rauch, Ursula]
通讯作者: Rauch, Ursula
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    10433906
  • 项目类别:
  • 资助金额:
    $48.91万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    10218114
  • 项目类别:
  • 资助金额:
    $46.19万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    9973158
  • 项目类别:
  • 资助金额:
    $40.06万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
Post-Graduate Hematology/Oncology Translational (PG-HOT) Training Program
  • 批准号:
    10647668
  • 项目类别:
  • 资助金额:
    $43.81万
  • 财政年份:
    2019
  • 负责人:
    VLADIMIR BOGDANOV
  • 依托单位:
海外基金